NIH-funded research R01 grant

Heart and liver of the heart: understanding heart damage in HIV-positive women in Africa

Official title: Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)

Funded at University of Washington · NIH-11398264 · Data updated 2026-11-12

This study will look at heart damage and fat buildup in the hearts of women with HIV in sub-Saharan Africa to understand what predicts progression.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 7, 2023
Project endMay 31, 2027
Funding year2026
Award (this year)$233,358
NIH project number5R01HL167645-04
Project IDNIH-11398264 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are ART-treated women with HIV in sub-Saharan Africa who may be at risk for myocardial fibrosis and steatosis.

Less likely to help

Some participants may not experience significant heart changes during the study.

What this research studies

Among women with HIV in sub-Saharan Africa, heart failure and related risks are a major concern. The study uses advanced heart imaging to measure fibrosis and fat in the heart, and will examine what factors predict worsening cardiac changes over time. The researchers aim to identify how inflammation, metabolic factors, and hormonal aging might drive these heart changes in ART-treated women. By following participants over time, the project hopes to find targets to prevent heart failure and sudden death in this population. This is a collaboration led by the University of Washington to address a critical health issue in a specific high-need group.

Why it matters

Potential benefit: If successful, the findings could guide personalized prevention and treatment to reduce heart damage and improve survival for HIV-infected women in SSA.

How similar studies have gone: Prior studies show that myocardial fibrosis and steatosis relate to worse heart outcomes, but this specific population has not been studied.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Longenecker, Chris Todd — University of Washington
  • Study coordinator: Longenecker, Chris Todd

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.